Literature DB >> 2296619

Idazoxan increases rough-and-tumble play, activity and exploration in juvenile rats.

S M Siviy1, D M Atrens, J A Menendez.   

Abstract

The effects of idazoxan, an alpha-2 noradrenergic antagonist, on play and open field behavior were assessed in juvenile rats. Play was assessed in two separate paradigms. Initially, juvenile rats were housed individually and given a daily 5 min opportunity to play with a responsive partner. Idazoxan (1-8 mg/kg) increased pinning, an indicator variable of play, but did not affect the frequency of dorsal contacts, an index of play solicitation. When rats were tested in a separate test for play solicitation using an unresponsive play partner, idazoxan increased all three measures of play solicitation. Idazoxan increased activity and exploration when rats were tested in an open field, suggesting that the effects of idazoxan on play may be due to an increase in behavioral arousal and/or attention. These data are consistent with a modulatory role for norepinephrine in the control of behavior.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2296619     DOI: 10.1007/bf02245801

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

Review 1.  The contribution of behavioural studies to the neuropharmacology of anxiety.

Authors:  S E File
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

2.  Brain monoamines and peptides: role in the control of eating behavior.

Authors:  S F Leibowitz
Journal:  Fed Proc       Date:  1986-04

3.  Effects of clonidine and yohimbine on the social play of juvenile rats.

Authors:  L Normansell; J Panksepp
Journal:  Pharmacol Biochem Behav       Date:  1985-05       Impact factor: 3.533

4.  Catecholamines and aggression in animals.

Authors:  R Bell; P G Hepper
Journal:  Behav Brain Res       Date:  1987-01       Impact factor: 3.332

5.  Evidence for the involvement of presynaptic alpha-2 adrenoceptors in the regulation of norepinephrine metabolism in the rat brain.

Authors:  O Curet; T Dennis; B Scatton
Journal:  J Pharmacol Exp Ther       Date:  1987-01       Impact factor: 4.030

6.  Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice.

Authors:  M J Durcan; R G Lister; M Linnoila
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors.

Authors:  W W Beatty; K B Costello; S L Berry
Journal:  Pharmacol Biochem Behav       Date:  1984-05       Impact factor: 3.533

8.  Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.

Authors:  J E Freedman; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

9.  Comparison of the effects of recently developed alpha 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain.

Authors:  D J Pettibone; A B Pfleuger; J A Totaro
Journal:  Biochem Pharmacol       Date:  1985-04-01       Impact factor: 5.858

10.  Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP-4, a selective noradrenergic neurotoxin.

Authors:  D J Dooley; H Bittiger; K L Hauser; S F Bischoff; P C Waldmeier
Journal:  Neuroscience       Date:  1983-08       Impact factor: 3.590

View more
  2 in total

1.  How strain differences could help decipher the neurobiology of mammalian playfulness: What the less playful Fischer 344 rat can tell us about play.

Authors:  Stephen M Siviy
Journal:  Int J Play       Date:  2020-02-09

2.  Effects of alpha-2 adrenoceptor antagonists on rough-and-tumble play in juvenile rats: evidence for a site of action independent of non-adrenoceptor imidazoline binding sites.

Authors:  S M Siviy; A E Fleischhauer; S J Kuhlman; D M Atrens
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.